The early detection of cancer leads to less aggressive treatments, better survival rates and a longer life expectancy.
Where is Manchester now
Greater Manchester is more deprived than the average for England as a whole and has a higher proportion of its residents from a Black and minority ethnic (BME) background. These factors impact on cancer risk, access to services and capacity to benefit from therapies and so we might expect outcomes to be poorer than in England.
Despite this, one-year survival from cancer – an indicator of the stage of cancer at the time of diagnosis – is higher in Greater Manchester than it is in England as a whole. This is testament (in part) to the combined efforts of public health, health promoters, clinicians and the community.
But there is also concern that there is a significant difference in the one-year survival between each category of socioeconomic status in the population and addressing these inequalities will be fundamental for our strategy and our interventions need to be tailored and adapted to ensure that these disparities do not persist or increase in the future.
The Macmillan Cancer Improvement Partnership is bringing together all cancer care providers in Manchester to improve the experience of everybody affected by cancer at every stage of their cancer journey.
To read a full report on early diagnosis and related issues, click here.
Please see the links below for details on our screening programmes:
UK Screening Portal
Greater Manchester bowel movement
Greater Manchester Breast Screening Programme